Retinoid-related orphan nuclear receptors (RORs) ␣ and ␥ (NR1F1, -3) are highly expressed in liver, adipose tissue, thymus, and brain and are involved in many physiological processes, such as circadian rhythm and immune function. Enzymes in the cytochrome P450 2C subfamily metabolize many clinically important drugs and endogenous compounds, such as the anticancer drug paclitaxel and arachidonic acid, and are highly expressed in liver. Here, we present the first evidence that RORs regulate the transcription of human CYP2C8. Overexpression of ROR␣ and ROR␥ in HepG2 cells significantly enhanced the activity of the CYP2C8 promoter but not that of the CYP2C9 or CYP2C19 promoters. Computer analyses, promoter deletion studies, gel shift assays, and mutational analysis identified an essential ROR-responsive element at Ϫ2045 base pairs in the CYP2C8 promoter that mediates ROR transactivation. Adenoviral overexpression of ROR␣ and -␥ significantly induced endogenous CYP2C8 transcripts in both HepG2 cells and human primary hepatocytes. Knockdown of endogenous ROR␣ and -␥ expression in HepG2 cells by RNA interference decreased the expression of endogenous CYP2C8 mRNA by ϳ50%. These data indicate that RORs transcriptionally upregulate CYP2C8 in human liver and, therefore, may be important modulators of the metabolism of drugs and physiologically active endogenous compounds by this enzyme in liver and possibly extrahepatic tissues where RORs are expressed.The human CYP2C subfamily consists of four genes: CYP2C8, CYP2C9, CYP2C18, and CYP2C19. CYP2C18 does not seem to be expressed at the protein level. The other three CYP2C enzymes metabolize approximately 20% of currently used clinical drugs, including the antidiabetic drugs tolbutamide and rosiglitazone, the anticoagulant drug warfarin, the anticonvulsant phenytoin, the antiulcer drug omeprazole, the anticancer drug paclitaxel, and numerous nonsteroidal antiinflammatory drugs, such as ibuprofen (Goldstein, 2001). They are also involved in the oxidative metabolism of endogenous compounds, such as arachidonic acid and retinoic acid.It is well known that there is marked variability in the metabolism of CYP2C substrates in human populations because of the occurrence of genetic polymorphisms in the CYP2C genes. The expression of CYP2C enzymes also has been reported to be induced by various drugs, including rifampicin, hyperforin (the active constituent in St. John's Wort), phenobarbital, and dexamethasone (Raucy et al., 2002;Madan et al., 2003;Komoroski et al., 2004). This induction further amplifies the individual variability in drug metabolism in human populations and may lead to a change in the half-life of drugs and then eventually result in drug tolerance or therapeutic failure.A number of nuclear receptors have been discovered to play important roles in the mediation of transactivation of P450 enzymes. In many cases, these nuclear receptors bind ligands, which may be involved in initiating translocation of the receptor to the nucleus, where the receptor binds to resp...